Download the latest data exploring milestones from the two Microbiome approvals.
What’s covered in the infographic:
- Overview of the use of FMT therapies for the prevention of CDI and CDI recurrence
- Timeline of key milestones for both REBYOTA and VOWST
- Predicted milestones
To learn more about the infographic and how Beacon Microbiome can enhance your data needs and provide fast insights please book a research session below or contact us directly on beacon@hansonwade.com.
Find out more
Speak with our Team of Experts
Our dedicated team is on hand to showcase how Beacon can help you find the answers to your microbiome-related questions.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements.
